Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mach

Showing results (151-160 of 250) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulationW Reith, E Barras, S Satola, et al.
Nucleic Acids Research|June 20, 1998
DNA binding properties of a chemically synthesized DNA binding domain of hRFX1F Cornille, P Emery, W Schüler, et al.
Molecular and Cellular Biology|October 1, 1993
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerC A Siegrist, B Durand, P Emery, et al.
British Journal of Haematology|October 1, 1993
Replacement of HLA class II serology by the HLA-DR microtitre plate oligotyping assay: a one-year experience in unrelated bone marrow donor selectionJ M Tiercy, E Roosnek, D Speiser, et al.
Genes & Development|May 1, 1995
A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)V Steimle, B Durand, E Barras, et al.
The New England Journal of Medicine|September 11, 1997
Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiencyJ Villard, B Lisowska-Grospierre, P van den Elsen, et al.
The Journal of Clinical Investigation|July 1, 1985
A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndromeB Lisowska-Grospierre, D J Charron, C de Préval, et al.
The Journal of Biological Chemistry|November 5, 1993
Clathrin-coated pit-mediated receptor internalization. Role of internalization signals and receptor mobilityJ P Paccaud, W Reith, B Johansson, et al.
Schweizerische Medizinische Wochenschrift|November 27, 1993
[A new method of HLA-DR typing using molecular biology: 1-year experience in bone marrow transplantation]J M Tiercy, E Roosnek, D Speiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell typesJ Berdoz, J Gorski, A M Termijtelen, et al.
Pageof 25

Showing results (151-160 of 250) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulationW Reith, E Barras, S Satola, et al.
Nucleic Acids Research|June 20, 1998
DNA binding properties of a chemically synthesized DNA binding domain of hRFX1F Cornille, P Emery, W Schüler, et al.
Molecular and Cellular Biology|October 1, 1993
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerC A Siegrist, B Durand, P Emery, et al.
British Journal of Haematology|October 1, 1993
Replacement of HLA class II serology by the HLA-DR microtitre plate oligotyping assay: a one-year experience in unrelated bone marrow donor selectionJ M Tiercy, E Roosnek, D Speiser, et al.
Genes & Development|May 1, 1995
A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)V Steimle, B Durand, E Barras, et al.
The New England Journal of Medicine|September 11, 1997
Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiencyJ Villard, B Lisowska-Grospierre, P van den Elsen, et al.
The Journal of Clinical Investigation|July 1, 1985
A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndromeB Lisowska-Grospierre, D J Charron, C de Préval, et al.
The Journal of Biological Chemistry|November 5, 1993
Clathrin-coated pit-mediated receptor internalization. Role of internalization signals and receptor mobilityJ P Paccaud, W Reith, B Johansson, et al.
Schweizerische Medizinische Wochenschrift|November 27, 1993
[A new method of HLA-DR typing using molecular biology: 1-year experience in bone marrow transplantation]J M Tiercy, E Roosnek, D Speiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell typesJ Berdoz, J Gorski, A M Termijtelen, et al.
Pageof 25